Entera Bio Ltd.

Entera Bio Ltd. - PE Ratioverified

ENTX

Price:

$1.21

Market Cap:

$59.64M

Entera Bio Ltd. is a biopharmaceutical firm in the clinical development phase, dedicated to creating and marketing oral medications composed of large molecules, addressing medical conditions that currently lack adequate treatments. Its primary experimental drugs are EB612, currently undergoing Phase II clinical assessment for hypoparathyroidism, and EB613, which has concluded Phase II studies for osteoporosis and is now in Phase I trials for treating non-healing bone fractures. Furthermore, the company holds a collaborative research and licensing pact with Amgen Inc. aimed at identifying and advancing potential therapeutic compounds for inflammatory conditions and other grave ailments. Estab...[Read more]

Industry

Biotechnology

IPO Date

2018-06-28

Stock Exchange

NASDAQ

Ticker

ENTX

The PE Ratio as of June 2026 (TTM) for Entera Bio Ltd. (ENTX) is -4.65

According to Entera Bio Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -4.65. This represents a change of -30.19% compared to the average of -6.66 of the last 4 quarters.

Entera Bio Ltd. (ENTX) Historical PE Ratio (quarterly & annually)

How has ENTX PE Ratio performed in the past?

The mean historical PE Ratio of Entera Bio Ltd. over the last ten years is -8.32. The current -4.65 PE Ratio has changed 5.49% with respect to the historical average. Over the past ten years (40 quarters), ENTX's PE Ratio was at its highest in in the September 2024 quarter at 5.92. The PE Ratio was at its lowest in in the December 2016 quarter at -15.70.

Quarterly (TTM)
Annual

Average

-8.32

Median

-4.07

Minimum

-44.86

Maximum

-1.62

Entera Bio Ltd. (ENTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Entera Bio Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 338.13%

Maximum Annual PE Ratio = -1.62

Minimum Annual Increase = -89.31%

Minimum Annual PE Ratio = -44.86

Quarterly (TTM)
Annual
YearPE RatioChange
2025-7.76-8.49%
2024-8.48338.13%
2023-1.9419.31%
2022-1.62-72.96%
2021-6.00200.00%
2020-2.00-15.89%
2019-2.38-29.06%
2018-3.35-30.09%
2017-4.79-89.31%
2016-44.86157.14%

Entera Bio Ltd. (ENTX) Average PE Ratio

How has ENTX PE Ratio performed in the past?

The current PE Ratio of Entera Bio Ltd. (ENTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.06

5-year avg

-5.16

10-year avg

-8.32

Entera Bio Ltd. (ENTX) PE Ratio vs. Peers

How is ENTX’s PE Ratio compared to its peers?

Entera Bio Ltd.’s PE Ratio is greater than Anixa Biosciences, Inc. (-9.76), less than VistaGen Therapeutics, Inc. (-0.36), less than Opus Genetics, Inc. (-3.11), less than Seer, Inc. (-1.40), less than TuHURA Biosciences, Inc. (-4.19), less than Acumen Pharmaceuticals, Inc. (-1.21), less than Seres Therapeutics, Inc. (-1.28), less than Spero Therapeutics, Inc. (8.45), less than Agenus Inc. (1.73), less than Inovio Pharmaceuticals, Inc. (-0.65),

Build a custom stock screener for Entera Bio Ltd. (ENTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entera Bio Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Entera Bio Ltd. (ENTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Entera Bio Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Entera Bio Ltd.'s PE Ratio?

How is the PE Ratio calculated for Entera Bio Ltd. (ENTX)?

What is the highest PE Ratio for Entera Bio Ltd. (ENTX)?

What is the 3-year average PE Ratio for Entera Bio Ltd. (ENTX)?

What is the 5-year average PE Ratio for Entera Bio Ltd. (ENTX)?

How does the current PE Ratio for Entera Bio Ltd. (ENTX) compare to its historical average?